Medical Fair Asia 2022, Singapore

Medical Fair Asia 2022 was a momentous event for IntegriMedical. We introduced our ingenious product at the expo, showcasing our innovation and technological advancement in drug delivery solutions, parallel to none.

Read more@ https://integrimedical.com/medical-fair-asia-singapore

Comments

Post a Comment

Popular posts from this blog

Serum Institute of India acquires 20% stake in IntegriMedical

 The largest vaccine manufacturer in the world, Serum Institute of India (SII), purchased a 20% share in IntegriMedical, a US-based company, in order to further the development of needle-free injection system technology. The deal’s financial specifics were kept under wraps. In a statement released on Friday, Pune-based SII said that the collaboration with IntegriMedical is in line with both company’s goals of “Health for All” and “Transforming Healthcare Globally” through the provision of patient comfort, assurance of improved patient compliance, a decrease in needle-stick injuries, and an improvement in the effectiveness of liquid medication through needle-free dispersion. Read more@ https://www.indiainfoline.com/news/companies/serum-institute-acquires-20-stake-in-integrimedical
Read more

Intramuscular Injections

Choose Needle-Free Injection System for Painless Subcutaneous and Intramuscular Injections With IntegriMedical’s Needle-Free Injection System, the process of taking subcutaneous and intramuscular injections is less painful. Manufactured using cutting-edge technology, needle-free injection system makes injections painless. Read more@ https://integrimedical.com/ 
Read more

Needle Free Injection

Make Vaccinations Anxiety-Free with Needle-Free Injections Does the idea of vaccinations make your kids anxious?IntegriMedical’s Needle-free injectionsare the perfect solution for their anxiety.Be it administering insulin, vaccine, or hormones, the Needle-Free Injection System makes the entire process easy, effective, and less painful. Read more@ https://integrimedical.com/
Read more